This certainly seems to be the month of the “brain devices”. Just last week the FDA approved one magnetic device to zap your brain and now we have another company from Israel to begin trials in Israel and 2 other areas. The device approved for last week is only for severe cases of depression, but this unit looks like it it set up to take on a lot more, Bi-Polar and Obesity. Obesity is a big problem in the world and even more so in the US, perhaps we might be just a few years away from a few zaps to help out.
(TMS) is what the treatment plan is called, so it would appear we might be hearing this word a lot more in the future. The Brainsway machine looks a little more heavy duty too than the one from Neurostar.
From the website:
The patient is seated on a chair, with his head resting comfortably on a head support. The patient is fitted with ear plugs to attenuate the sound if the TMS pulses. The H Coil is put onto the patient's head at the location appropriate for motor stimulation of the hand. EMG recording electrodes are connected to the hand muscle, and motor evoked potentials are recorded, for determination of the desired TMS intensity.
the head at the optimal location for treatment. The treatment is composed of a session of trains of TMS pulses, typically delivered for a period of 10-20 minutes. In accepted treatment protocols, the same treatment is applied on consecutive days over several weeks. The treatment has no significant side effects. The most prominent sensation felt by the patient during treatment is a small vibration of the coil elements over the head.
With all the new devices coming out recently, perhaps out dependence for medications in some areas could stand to decrease. All the TMS devices still leave me with visions of “One Flew over the Cuckoo’s Nest” though, but my own thoughts there. It does make you wonder where we will all be in a few years from now, as you can already order your do it at home Bi-Polar test for $399, so who knows, get your kit, take the results in and get zapped, but by that time you will have your complete genomics sequencing already completed and more than likely be carrying the gene for it anyway (grin). BD
Brainsway gets FDA nod for device trial The company plans to begin a multi-center trial of its deep Transcanial Magnetic Stimulation device soon. Globes' correspondent26 Oct 08 12:14 Brainsway Ltd. (TASE:BRIN) has obtained US Food and Drug Administration (FDA) approval for its Investigational Device Exemptions (IDE) application for a clinical trial of its deep Transcanial Magnetic Stimulation device for the treatment of depression. The company plans to obtain institutional review board (IRB) approval from medical centers in the US, Europe, and Israel for the multi-center trial, which it expects to begin soon. Brainsway has developed a method for treating neurological and cognitive disorders by magnetic stimulation of the brain, with differing disorders treated by focusing on specific sites in the brain.